PRGO:NYSEPerrigo Company plc Analysis
Data as of 2026-04-25 - not real-time
$11.82
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Perrigo trades around $11.82, comfortably above its 20‑day ($11.09) and 50‑day ($11.48) moving averages but still well below the 200‑day average of $17.25, signaling a long‑term bearish backdrop. The stock sits near its technical resistance at $12.13 with support around $9.25, while a bullish MACD crossover and an RSI of 59 suggest short‑term momentum could linger despite decreasing volume and a 30‑day volatility of 49%.
Fundamentally, PRGO appears markedly undervalued: a forward P/E of 4.97 versus an industry average of 25.4, a price‑to‑book of 0.55, and analyst price targets averaging $16.5‑$17 imply upside of roughly 44%. However, the company carries a heavy debt load (debt‑to‑equity ≈ 131%), a negative net margin, and a dividend payout ratio exceeding 100%, raising concerns about dividend sustainability and financial resilience.
Fundamentally, PRGO appears markedly undervalued: a forward P/E of 4.97 versus an industry average of 25.4, a price‑to‑book of 0.55, and analyst price targets averaging $16.5‑$17 imply upside of roughly 44%. However, the company carries a heavy debt load (debt‑to‑equity ≈ 131%), a negative net margin, and a dividend payout ratio exceeding 100%, raising concerns about dividend sustainability and financial resilience.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram with RSI in neutral range
- Proximity to technical resistance at $12.13
- Decreasing volume and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of 4.97 versus industry 25.4 indicating strong value upside
- Analyst consensus of "buy" with median target $16.5
- Potential upside of ~44% based on target pricing
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio (~131%) limiting financial flexibility
- Unsustainable dividend payout (>100% of earnings)
- Long‑term bearish trend reflected by price below 200‑day SMA
Key Metrics & Analysis
Financial Health
Revenue Growth-2.50%
Profit Margin-33.51%
P/E Ratio5.0
ROE-38.66%
ROA2.35%
Debt/Equity131.16
P/B Ratio0.6
Op. Cash Flow$238.5M
Free Cash Flow$28.3M
Industry P/E25.4
Technical Analysis
TrendBearish
RSI59.0
Support$9.25
Resistance$12.13
MA 20$11.09
MA 50$11.48
MA 200$17.25
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02
Valuation
Target Price$17.00
Upside/Downside43.82%
GradeUndervalued
TypeValue
Dividend Yield9.81%
Risk Assessment
Beta1.16
Volatility49.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.